2014 Medicare Prescription Drug Price Information | ||||||
Cigna-HealthSpring Rx -Reg 25 (PDP) (S5932-024-0) Benefit Details ![]() ![]() ![]() ![]() | ||||||
Monthly Premium: $50.00 Rx Deductible: $310 ICL: $2,850 Qualifies for LIS: No Click on a letter below to view the Cigna-HealthSpring Rx -Reg 25 (PDP) Formulary A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9 | ||||||
METHSCOPOLAMINE BROMIDE 2.5MG TABLET ![]() | ||||||
Plan’s average negotiated retail drug price in CMS PDP Region 25, includes: IA MN MT NE ND SD WY | $164.23* 30-Day Supply $490.00* 90-Day Supply | |||||
Formulary (Drug List) drug tier: | Tier #1: On Formulary | |||||
Does this plan offer any Gap coverage? | No Gap Coverage | |||||
Does this drug have Gap coverage? | No, this drug IS NOT covered in the gap, but all drugs receive the donut hole discount. | |||||
Drug Usage Management Restrictions: | None | |||||
Formulary (Drug List) Tier Cost-Sharing Details | ||||||
30-Day Supply Cost-Sharing |
90-Day Supply Cost-Sharing |
|||||
Preferred Pharmacy | Standard Pharmacy | Mail- Order** | Preferred Pharmacy | Standard Pharmacy | Mail- Order** | |
Initial $310 Deductible Cost Sharing: | ||||||
100% | 100% | 100% | 100% | 100% | 100% | |
Initial Coverage Phase Cost-Sharing: | ||||||
25% | 25% | 25% | 25% | 25% | 25% | |
Coverage Gap Phase Cost-Sharing Incl. Donut Hole Discount (Generics 28%): | ||||||
79% | 79% | 79% | 79% | 79% | 79% | |
Coverage Gap Phase Cost-Sharing Incl. Donut Hole Discount (Brand 52.5%): | ||||||
47.5% | 47.5% | 47.5% | 47.5% | 47.5% | 47.5% | |
Catastrophic Coverage Phase Cost-Sharing for Generic & Preferred Multi-Source Drugs: | ||||||
The greater of 5% or $2.55 | The greater of 5% or $2.55 | |||||
Catastrophic Coverage Phase Cost-Sharing for Other Drugs (Brand-Name or Non-Preferred Multi-Source Drugs): | ||||||
The greater of 5% or $6.35 | The greater of 5% or $6.35 | |||||
Your Estimated Cost for Purchases During Each Coverage Phase | ||||||
30-Day Supply Cost-Sharing |
90-Day Supply Cost-Sharing |
|||||
Preferred Pharmacy | Standard Pharmacy | Mail- Order** | Preferred Pharmacy | Standard Pharmacy | Mail- Order** | |
Your Estimated Cost in Deductible Phase: | ||||||
$164.23 | $164.23 | $164.23 | $355.00 | $355.00 | $355.00 | |
Your Estimated Cost Initial Coverage Phase: | ||||||
$41.06 | $41.06 | $41.06 | $122.50 | $122.50 | $122.50 | |
Your Estimated Cost in Gap if Drug is Generic (28% discount): | ||||||
$129.74 | $129.74 | $129.74 | $387.10 | $387.10 | $387.10 | |
Your Estimated Cost in Gap if Drug is Brand-Name (52.5% discount): | ||||||
$78.01 | $78.01 | $78.01 | $232.75 | $232.75 | $232.75 | |
Your Estimated Cost in Catastrophic Coverage Phase (Generic): | ||||||
$8.21 | $8.21 | $8.21 | $24.50 | $24.50 | $24.50 | |
Your Estimated Cost in Catastrophic Coverage (Brand-Name or Non-Preferred Multi-Source Drugs): | ||||||
$8.21 | $8.21 | $8.21 | $24.50 | $24.50 | $24.50 | |
Tier Cost-Sharing Details and Your Costs with Explanations | ||||||
30-Day Supply Cost-Sharing |
90-Day Supply Cost-Sharing |
|||||
Preferred Pharmacy | Standard Pharmacy | Mail- Order** | Preferred Pharmacy | Standard Pharmacy | Mail- Order** | |
--- If you purchase during the Initial Deductible Phase --- | ||||||
Initial $310 Deductible Cost Sharing: | ||||||
100% | 100% | 100% | 100% | 100% | 100% | |
Your Estimated Cost in Deductible Phase: | ||||||
$164.23 | $164.23 | $164.23 | $355.00 | $355.00 | $355.00 | |
Explanation for 30-Day Preferred Pharmacy purchase: | ||||||
In the initial deductible phase, you will pay 100% of the drug cost up to your deductible limit of $310. Any excess would fall into the initial coverage phase. | ||||||
--- If you purchase during the Initial Coverage Phase --- | ||||||
Initial Coverage Phase Cost-Sharing: | ||||||
25% | 25% | 25% | 25% | 25% | 25% | |
Your Estimated Cost Initial Coverage Phase: | ||||||
$41.06 | $41.06 | $41.06 | $122.50 | $122.50 | $122.50 | |
Explanation for 30-Day Preferred Pharmacy purchase: | ||||||
The cost-sharing for purchases made during the initial coverage phase (ICP) would be $41.06 or ($164.23 x 25%). | ||||||
--- If you purchase during the Coverage Gap Phase (Donut Hole) --- | ||||||
Your Estimated Cost in Gap if Drug is Generic (28% discount): | ||||||
$129.74 | $129.74 | $129.74 | $387.10 | $387.10 | $387.10 | |
Explanation for 30-Day Preferred Pharmacy purchase: | ||||||
Your cost is the negotiated retail price of $164.23 x 79%. | ||||||
Your Estimated Cost in Gap if Drug is Brand-Name (52.5% discount): | ||||||
$78.01 | $78.01 | $78.01 | $232.75 | $232.75 | $232.75 | |
Explanation for 30-Day Preferred Pharmacy purchase: | ||||||
Your costs is the negotiated retail price of $164.23 x 47.5%. | ||||||
--- If you purchase during the Catastrophic Coverage Phase --- | ||||||
Catastrophic Coverage Phase Cost-Sharing for Generic & Preferred Multi-Source Drugs: | ||||||
The greater of 5% or $2.55 | The greater of 5% or $2.55 | |||||
Your Estimated Cost in Catastrophic Coverage Phase (Generic): | ||||||
$8.21 | $8.21 | $8.21 | $24.50 | $24.50 | $24.50 | |
Explanation for 30-Day Preferred Pharmacy purchase: | ||||||
In the catastrophic coverage phase, you will pay the greater of 5% of the retail drug price or the minimum cost-share of $2.55. Calculating 5% of $164.23 = $8.21. Since $8.21 is more than $2.55, you would pay $8.21 for this drug at a preferred pharmacy, if it is a generic or preferred multi-source drug. | ||||||
Catastrophic Coverage Phase Cost-Sharing for Other Drugs (Brand-Name or Non-Preferred Multi-Source Drugs): | ||||||
The greater of 5% or $6.35 | The greater of 5% or $6.35 | |||||
Your Estimated Cost in Catastrophic Coverage (Brand-Name or Non-Preferred Multi-Source Drugs): | ||||||
$8.21 | $8.21 | $8.21 | $24.50 | $24.50 | $24.50 | |
Explanation for 30-Day Preferred Pharmacy purchase: | ||||||
In the catastrophic coverage phase, you will pay the greater of 5% of the retail drug price or the minimum cost-share of $6.35. Calculating 5% of $164.23 = $8.21. Since $8.21 is more than $6.35, you would pay $8.21 for this drug at any pharmacy, if it is not a generic or preferred multi-source drug. | ||||||
Cigna-HealthSpring Rx -Reg 25 (PDP) Average Negotiated Retail Drug Price History | ||||||
30-Day Supply | 90 Day Supply | |||||
September, 2014: | $164.23 | $490.00 | ||||
June, 2014: | $159.54 | $475.93 | ||||
March, 2014: | $177.82 | $530.79 | ||||
January, 2014: | $187.49 | $559.81 | ||||
October, 2013: | $190.97 | $570.27 | ||||
January, 2013: | $193.93 | -- | ||||
April, 2012: | $195.63 | -- | ||||
September, 2010: | $154.22 | -- | ||||
Notes:
*The Medicare drug plan’s average negotiated retail drug price is based on several variables: the medication, the quantity of your prescription, the specific Medicare Part D plan, and the pharmacies in the plan’s service area. In this case, the average of the METHSCOPOLAMINE BROMIDE 2.5MG TABLET prices that the Cigna-HealthSpring Rx -Reg 25 (PDP) has negotiated with each of the retail pharmacies in the plan’s service area (CMS PDP Region 25, includes: IA MN MT NE ND SD WY). In other words, when you use the Cigna-HealthSpring Rx -Reg 25 (PDP) to purchase METHSCOPOLAMINE BROMIDE 2.5MG TABLET, you may pay slightly more or slightly less than the figures shown in the table above depending on the pharmacy where you fill your prescription and the quantity of your prescription. **The mail-order cost-sharing is the plan’s "preferred" mail-order cost-sharing. |
||||||
Return to the Cigna-HealthSpring Rx -Reg 25 (PDP) 2014 Formulary Browser by choosing a letter below: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9 |